SUN Wenjuan, ZOU Yuzhen, ZHANG Fan, ZHANG Lu, ZHAO Lin, BAI Chunmei, ZHANG Feng, XU Yan, MAO Feng, LI Jing, GU Yu, FAN Xinrong, WANG Mengzhao, ZHOU Daobin, ZHANG Zhanjie, ZHAO Bin, DU Xiaoli, ZHANG Bo, SUN Xueqin, LONG Xiao, CHANG Qing, HU Bingshui, PAN Hui, WU Wenming. Design and Analysis of the Operation Effect of the Safety Management System for Antitumor Drugs[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(3): 461-467. DOI: 10.12290/xhyxzz.2021-0704
Citation: SUN Wenjuan, ZOU Yuzhen, ZHANG Fan, ZHANG Lu, ZHAO Lin, BAI Chunmei, ZHANG Feng, XU Yan, MAO Feng, LI Jing, GU Yu, FAN Xinrong, WANG Mengzhao, ZHOU Daobin, ZHANG Zhanjie, ZHAO Bin, DU Xiaoli, ZHANG Bo, SUN Xueqin, LONG Xiao, CHANG Qing, HU Bingshui, PAN Hui, WU Wenming. Design and Analysis of the Operation Effect of the Safety Management System for Antitumor Drugs[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(3): 461-467. DOI: 10.12290/xhyxzz.2021-0704

Design and Analysis of the Operation Effect of the Safety Management System for Antitumor Drugs

More Information
  • Corresponding author:

    ZHAO Bin, E-mail: zhaobin@pumch.cn

  • Received Date: October 20, 2021
  • Accepted Date: January 17, 2022
  • Available Online: March 04, 2022
  • Issue Publish Date: May 29, 2022
  •   Objective  To design a safety management system for antitumor drugs, which can intercept or warn the overdose of medical orders from the prescription source, and ensure the safety of clinical application of antitumor drugs.
      Methods  The threshold of interception and warning strategy of 88 kinds of antitumor drugs were developed, and the safety management system of antitumor drugs was established to intercept or warn the overdose orders. The interception and warning data from January 2021 to June 2021 in the safety management system of antitumor drugs were extracted and analyzed.
      Results  A total of 665 medical orders were intercepted or warned by the safety management system of antitumor drugs, and the majority of the intercepted or warned drugs were oral tablets(74.29%). The intercepted orders were 642 (96.54%), and the warned orders were 23(3.46%). Among the intercepted medical orders, frequency error (64.22%) has the highest proportion, followed by route error (11.73%) and dose error (9.92%). A total of 564 medical orders were intercepted, involving 28 kinds of antitumor drugs. Methotrexate tablets ranked first in overdose quantity, with an average of seven times. Pemetrexed ranked first in overdose multiples, with an average overdose of 1000 times. 78 medical orders were intercepted for over pathway, involving 5 kinds of antitumor drugs.
      Conclusion  The safety management system of antitumor drugs can eliminate the error of overdose in prescription and guarantee the safety of antitumor drugs.
  • [1]
    World Health Organization. Feedback format for providing comments/suggestions on the draft Global Patient Safety Action Plan 2021-2030[EB/OL ]. (2020-08-28)[2021-10-21]. https://extranet.who.int/dataformv3/index.php/959279?lang=en.
    [2]
    Hedegaard H, Miniño AM, Warner M. Drug Overdose Deaths in the United States, 1999—2018[J]. NCHS Data Brief, 2020(356): 1-8.
    [3]
    Okumura Y, Sakata N, Takahashi K, et al. Epidemiology of overdose episodes from the period prior to hospitalization for drug poisoning until discharge in Japan: An exploratory descriptive study using a nationwide claims database[J]. J Epidemiol, 2017, 27: 373-380. DOI: 10.1016/j.je.2016.08.010
    [4]
    Institute for Safe Medication Practices. High-Alert Medica-tions in Long-Term Care (LTC) Settings[EB/OL ]. (2021-05-20)[2021-10-21]. https://www.ismp.org/recommendations/high-alert-medications-long-term-care-list.
    [5]
    Jung HK, Lee J, Lee SN. A case of massive cisplatin overdose managed by plasmapheresis[J]. Korean J Intern Med, 1995, 10: 150-154. DOI: 10.3904/kjim.1995.10.2.150
    [6]
    Hofmann G, Bauernhofer T, Krippl P, et al. Plasma-pheresis reverses all side-effects of a cisplatin overdose-a case report and treatment recommendation[J]. BMC Cancer, 2006, 6: 1-1. DOI: 10.1186/1471-2407-6-1
    [7]
    Chae L, Moon HS, Kim SC. Overdose of vincristine: experience with a patient[J]. J Korean Med Sci, 1998, 13: 334-338. DOI: 10.3346/jkms.1998.13.3.334
    [8]
    Patiroglu T, Unal E, Ozdemir MA, et al. Accidental intramuscular overdose administration of vincristine[J]. Drug Chem Toxicol, 2012, 35: 232-234. DOI: 10.3109/01480545.2011.604676
    [9]
    Iketani O, Ueda T, Yamayoshi Y, et al. Suicide attempt with an overdose of imatinib[J]. Br J Clin Pharmacol, 2012, 74: 890-892. DOI: 10.1111/j.1365-2125.2012.04275.x
    [10]
    孙雯娟, 胡扬, 左玮, 等. 胃癌患者应用卡培他滨出现严重不良反应1例药学监护[J]. 临床药物治疗杂志, 2020, 18: 84-86. https://www.cnki.com.cn/Article/CJFDTOTAL-LCYW202001023.htm
    [11]
    Institute for Safe Medication Practices. Medication Errors in Outpatient Hematology and Oncology Clinics[EB/OL ]. (2017-12-01)[2021-10-21]. https://www.ismp.org/alerts/medication-errors-outpatient-hematology-and-oncology-clinics.
    [12]
    World Health Organization. Global cancer observatory[EB/OL]. (2021-01-01)[2021-10-21]. https://gco.iarc.fr/.
    [13]
    国家卫生健康委. 抗肿瘤药物临床应用管理办法(试行)[EB/OL ]. (2020-12-22)[2021-10-21]. http://www.nhc.gov.cn/yzygj/s7659/202012/a7600740bed44d1db7015ca5a1be2cc0.shtml.
    [14]
    陈新谦, 金有豫, 汤光. 新编药物学[M]. 第18版. 北京: 人民卫生出版社, 2018.
    [15]
    Vázquez-Cornejo E, Morales-Ríos O, Juárez-Villegas LE, et al. Medication errors in a cohort of pediatric patients with acute lymphoblastic leukemia on remission induction therapy in a tertiary care hospital in Mexico[J]. Cancer Med, 2019, 8: 5979-5987. DOI: 10.1002/cam4.2438
    [16]
    Weingart SN, Zhang L, Sweeney M, et al. Chemotherapy medication errors[J]. Lancet Oncol, 2018, 19: e191-e199. DOI: 10.1016/S1470-2045(18)30094-9
    [17]
    Ranchon F, Moch C, You B, et al. Predictors of prescription errors involving anticancer chemotherapy agents[J]. Eur J Cancer, 2012, 48: 1192-1199. DOI: 10.1016/j.ejca.2011.12.031
    [18]
    Ranchon F, Salles G, Späth HM, et al. Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costs[J]. BMC Cancer, 2011, 11: 2-10. DOI: 10.1186/1471-2407-11-2
    [19]
    Weingart SN, Mattsson T, Zhu J, et al. Improving Electronic Oral Chemotherapy Prescription: Can We Build a Safer System?[J]. J Oncol Pract, 2012, 8: e168-e173. DOI: 10.1200/JOP.2012.000677
    [20]
    Chaparro JD, Classen DC, Danforth M, et al. National trends in safety performance of electronic health record systems in children's hospitals[J]. Am Med Inform Assoc, 2017, 24: 268-274. DOI: 10.1093/jamia/ocw134
    [21]
    胡琳, 顾佳慧, 杜浩鑫, 等. 240例用药错误引发医疗损害责任纠纷的案件分析[J]. 中国药房, 2021, 32: 513-517. DOI: 10.6039/j.issn.1001-0408.2021.05.01
    [22]
    NMPA. 舒尼替尼说明书[EB/OL ]. (2020-08-17)[2021-10-21]. https://db.yaozh.com/Search?btn_jiansuo=1&content=%E8%88%92%E5%B0%BC%E6%9B%BF%E5%B0%BC.
    [23]
    NMPA. 替莫唑胺说明书[EB/OL ]. (2018-02-26)[2021-08-20]. https://db.yaozh.com/instruct?comprehensivese-archcontent=%E6%9B%BF%E8%8E%AB%E5%94%91%E8%83%BA&.
  • Cited by

    Periodical cited type(5)

    1. 韦室百,杨映霞,黄天敏. 基于ISMP医院用药安全自我评估标准的质量流程和风险管理的初评应用. 医学信息. 2025(02): 53-56 .
    2. 何蓉,枉前,伍萍,陈和莉. 抗肿瘤类仿制药品与原研药品说明书比较分析. 中国药业. 2024(22): 44-47 .
    3. 高时娟,言克莉,夏丽霞. 基于HFMEA模式的静脉化疗安全给药智能模块的设计与应用. 中国临床研究. 2023(02): 316-321 .
    4. 初翠英,张君利,李耀. 抗肿瘤药物药事管理实践与研究. 中国卫生标准管理. 2023(05): 143-146 .
    5. 姚瑶. 某医院呼吸内科病房药物安全管理的品管圈实践. 中医药管理杂志. 2023(06): 158-160 .

    Other cited types(0)

Catalog

    Article Metrics

    Article views (746) PDF downloads (61) Cited by(5)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close